Stocktoria

QUEST DIAGNOSTICS INC DGX

NYSE · stock · Services-Medical Laboratories · website · IPO 1996-12-17 · LEI

QUEST DIAGNOSTICS INC financials (annual)

Revenue
$7.21B $7.40B $7.53B $7.73B $9.44B $10.79B $9.88B $9.25B $9.87B $11.04B 2016201720182019202020212022202320242025
Net income
$645.0M $772.0M $736.0M $858.0M $1.43B $2.00B $946.0M $854.0M $871.0M $992.0M 2016201720182019202020212022202320242025
Free cash flow
$823.0M $923.0M $817.0M $843.0M $1.59B $1.83B $1.31B $864.0M $909.0M $1.36B 2016201720182019202020212022202320242025

Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$11.0B$9.9B$9.3B$9.9B$10.8B$9.4B$7.7B$7.5B$7.4B$7.2B
Gross profit$3.6B$2.7B$2.6B$2.7B$2.9B
SG&A expense$2.0B$1.8B$1.6B$1.9B$1.7B$1.6B$1.5B$1.4B$1.4B$1.4B
Operating income$1.6B$1.3B$1.3B$1.4B$2.4B$2.0B$1.2B$1.1B$1.2B$1.3B
Interest expense$163.0M$148.0M$152.0M$166.0M$180.0M$169.0M$153.0M$144.0M
Income tax$314.0M$273.0M$248.0M$264.0M$597.0M$460.0M$247.0M$182.0M$241.0M$429.0M
Net income$992.0M$871.0M$854.0M$946.0M$2.0B$1.4B$858.0M$736.0M$772.0M$645.0M
EPS (diluted)$8.75$7.69$7.49$7.97$15.55$10.47$6.28$5.29$5.50$4.51
Operating cash flow$1.9B$1.3B$1.3B$1.7B$2.2B$2.0B$1.2B$1.2B$1.2B$1.1B
Free cash flow$1.4B$909.0M$864.0M$1.3B$1.8B$1.6B$843.0M$817.0M$923.0M$823.0M
Cash & equivalents$420.0M$549.0M$686.0M$315.0M$872.0M$1.2B$1.2B$135.0M$137.0M$359.0M
Inventory$189.0M$188.0M$190.0M$192.0M$208.0M$223.0M$123.0M$99.0M$95.0M$82.0M
Total assets$16.2B$16.2B$14.0B$12.8B$13.6B$14.0B$12.8B$11.0B$10.5B$10.1B
Shareholders' equity$7.2B$6.8B$6.3B$5.9B$6.5B$6.8B$5.7B$5.3B$5.0B$4.7B

Growth · year-over-year · Revenue CAGR 4.8%

MetricFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue growth+11.8%+6.7%-6.4%-8.4%+14.3%+22.1%+2.6%+1.7%+2.6%-3.7%
Net income growth+13.9%+2.0%-9.7%-52.6%+39.4%+66.8%+16.6%-4.7%+19.7%-9.0%
EPS growth+13.8%+2.7%-6.0%-48.7%+48.5%+66.7%+18.7%-3.8%+22.0%-7.4%
Free cash flow growth+49.5%+5.2%-34.2%-28.2%+15.3%+88.3%+3.2%-11.5%+12.2%+47.5%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.